- Home
- Publications
- Publication Search
- Publication Details
Title
Cholangiocarcinoma — evolving concepts and therapeutic strategies
Authors
Keywords
-
Journal
Nature Reviews Clinical Oncology
Volume 15, Issue 2, Pages 95-111
Publisher
Springer Nature
Online
2017-10-10
DOI
10.1038/nrclinonc.2017.157
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extracellular Vesicles in Bile as Markers of Malignant Biliary Stenoses
- (2017) Valeria Severino et al. GASTROENTEROLOGY
- Detection of Cholangiocarcinoma by Assay of Methylated DNA Markers in Plasma
- (2017) Ju Dong Yang et al. GASTROENTEROLOGY
- PBRM1 loss is a late event during the development of cholangiocarcinoma
- (2017) Claudio Luchini et al. HISTOPATHOLOGY
- PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: updated survival data
- (2017) Pedro N Aguiar et al. Immunotherapy
- Gemox versus surveillance following surgery of localized biliary tract cancer: Results of the PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial.
- (2017) Julien Edeline et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune checkpoint inhibitors in malignancies with mismatch repair deficiency: a review of the state of the current knowledge
- (2017) Ali Naboush et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- A pharmacogenomic approach validates AG-221 as an effective and on-target therapy in IDH2 mutant AML
- (2017) L M Kats et al. LEUKEMIA
- Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family Inhibitor
- (2017) Timothy P.S. Perera et al. MOLECULAR CANCER THERAPEUTICS
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Overall Survival and Clinical Characteristics of BRCA‐Associated Cholangiocarcinoma: A Multicenter Retrospective Study
- (2017) Talia Golan et al. ONCOLOGIST
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Optimizing Next-Generation AML Therapy: Activity of Mutant IDH2 Inhibitor AG-221 in Preclinical Models
- (2017) Daniel Thomas et al. Cancer Discovery
- PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma
- (2017) Jacqueline Fontugne et al. Oncotarget
- Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH -Mutant Molecular Profiles
- (2017) Farshad Farshidfar et al. Cell Reports
- Harnessing the Immune System as a Therapeutic Tool in Virus-Associated Cancers
- (2017) Rafael Santana-Davila et al. JAMA Oncology
- Loss of ARID1A Expression Presents a Novel Pathway of Carcinogenesis in Biliary Carcinomas
- (2016) Motoko Sasaki et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Program Death 1 Immune Checkpoint and Tumor Microenvironment: Implications for Patients With Intrahepatic Cholangiocarcinoma
- (2016) Faiz Gani et al. ANNALS OF SURGICAL ONCOLOGY
- Is Radiotherapy Warranted Following Intrahepatic Cholangiocarcinoma Resection? The Impact of Surgical Margins and Lymph Node Status on Survival
- (2016) Abdulrahman Y. Hammad et al. ANNALS OF SURGICAL ONCOLOGY
- A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study
- (2016) John Bridgewater et al. BMC CANCER
- Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance
- (2016) Christopher H. Crane et al. CANCER
- Another solution that enables ablative radiotherapy for large liver tumors: Percutaneous interstitial high-dose rate brachytherapy
- (2016) Shyamal Patel et al. CANCER
- Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma
- (2016) Shinichi Yachida et al. CANCER CELL
- Immunotherapy against cancer-related viruses
- (2016) Haruko Tashiro et al. CELL RESEARCH
- Liver transplantation for “very early” intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment
- (2016) G. Sapisochin et al. HEPATOLOGY
- The underreporting of hepatocellular carcinoma to the cancer register and a log-linear model to estimate a more correct incidence
- (2016) Anna Törner et al. HEPATOLOGY
- A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma
- (2016) Sumera Rizvi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis
- (2016) Randa Tao et al. JOURNAL OF CLINICAL ONCOLOGY
- Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
- (2016) Theodore S. Hong et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase 2 study of BGJ398 in patients (pts) with advanced or metastatic FGFR-altered cholangiocarcinoma (CCA) who failed or are intolerant to platinum-based chemotherapy.
- (2016) Milind M. Javle et al. JOURNAL OF CLINICAL ONCOLOGY
- Next-Generation Sequencing and Fluorescence in Situ Hybridization Have Comparable Performance Characteristics in the Analysis of Pancreaticobiliary Brushings for Malignancy
- (2016) Jonathan C. Dudley et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- (2016) Jonathan E Rosenberg et al. LANCET
- Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise
- (2016) Supriya K. Saha et al. ONCOLOGIST
- Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic Cholangiocarcinoma
- (2016) S. K. Saha et al. Cancer Discovery
- Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation
- (2016) Marie-Claude Gingras et al. Cell Reports
- Does radiotherapy still have a role in unresected biliary tract cancer?
- (2016) Erqi L. Pollom et al. Cancer Medicine
- Epidemiology of cholangiocarcinoma
- (2015) Annika Bergquist et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Endoscopically inserted nasobiliary catheters for high dose-rate brachytherapy as part of neoadjuvant therapy for perihilar cholangiocarcinoma
- (2015) Saurabh Mukewar et al. ENDOSCOPY
- 525 Safety and efficacy of pembrolizumab (MK-3475) in patients (pts) with advanced biliary tract cancer: Interim results of KEYNOTE-028
- (2015) Y.J. Bang et al. EUROPEAN JOURNAL OF CANCER
- An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples
- (2015) Emily G. Barr Fritcher et al. GASTROENTEROLOGY
- Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma
- (2015) Kim Andresen et al. HEPATOLOGY
- SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
- (2015) Edgar Ben-Josef et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan–Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors
- (2015) Josep Tabernero et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: Molecular networks and biological concepts
- (2015) Chiara Raggi et al. JOURNAL OF HEPATOLOGY
- Abstract PL04-05: The first reported results of AG-120, a first-in-class, potent inhibitor of the IDH1 mutant protein, in a Phase I study of patients with advanced IDH1-mutant solid tumors, including gliomas
- (2015) Howard Burris et al. MOLECULAR CANCER THERAPEUTICS
- Genomic spectra of biliary tract cancer
- (2015) Hiromi Nakamura et al. NATURE GENETICS
- SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2
- (2015) Kimberly H Kim et al. NATURE MEDICINE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
- (2015) David M. Hyman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Adoptive Cell Therapy—Tumor-Infiltrating Lymphocytes, T-Cell Receptors, and Chimeric Antigen Receptors
- (2015) Steven A. Feldman et al. SEMINARS IN ONCOLOGY
- Hilar Cholangiocarcinoma: expert consensus statement
- (2015) John C. Mansour et al. HPB
- Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity
- (2015) Akihiro Fujimoto et al. Nature Communications
- Massive parallel sequencing uncovers actionable FGFR2–PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma
- (2015) Daniela Sia et al. Nature Communications
- Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cells
- (2015) Tae Won Kwak et al. JOURNAL OF NANOBIOTECHNOLOGY
- Geographic Variation of Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma, and Hepatocellular Carcinoma in the United States
- (2015) Sean F. Altekruse et al. PLoS One
- Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers
- (2015) Luisa Carbognin et al. PLoS One
- “Very Early” Intrahepatic Cholangiocarcinoma in Cirrhotic Patients: Should Liver Transplantation Be Reconsidered in These Patients?
- (2014) G. Sapisochin et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A phase I dose escalation study of oral c-MET inhibitor tivantinib (ARQ 197) in combination with gemcitabine in patients with solid tumors
- (2014) S. Pant et al. ANNALS OF ONCOLOGY
- Genomic Profiling of Intrahepatic Cholangiocarcinoma: Refining Prognosis and Identifying Therapeutic Targets
- (2014) Andrew X. Zhu et al. ANNALS OF SURGICAL ONCOLOGY
- S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma
- (2014) A B El-Khoueiry et al. BRITISH JOURNAL OF CANCER
- Human bile contains MicroRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis
- (2014) Ling Li et al. HEPATOLOGY
- Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma
- (2014) Rondell P. Graham et al. HUMAN PATHOLOGY
- Platelet-derived Growth Factor Primes Cancer-associated Fibroblasts for Apoptosis
- (2014) Sumera Rizvi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
- (2014) John Bridgewater et al. JOURNAL OF HEPATOLOGY
- Cholangiocarcinoma
- (2014) Nataliya Razumilava et al. LANCET
- EZH2 elevates the proliferation of human cholangiocarcinoma cells through the downregulation of RUNX3
- (2014) Bo Tang et al. MEDICAL ONCOLOGY
- FGFR3 Translocations in Bladder Cancer: Differential Sensitivity to HSP90 Inhibition Based on Drug Metabolism
- (2014) Jaime Acquaviva et al. MOLECULAR CANCER RESEARCH
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer of Unknown Primary Site
- (2014) Gauri R. Varadhachary et al. NEW ENGLAND JOURNAL OF MEDICINE
- New Routes to Targeted Therapy of Intrahepatic Cholangiocarcinomas Revealed by Next-Generation Sequencing
- (2014) J. S. Ross et al. ONCOLOGIST
- Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications
- (2014) Chaitanya R. Churi et al. PLoS One
- Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma
- (2014) Mitesh J. Borad et al. PLoS Genetics
- Systematic underreporting of the population-based incidence of pancreatic and biliary tract cancers
- (2013) Carl Kilander et al. ACTA ONCOLOGICA
- A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe
- (2013) P. Bertuccio et al. ANNALS OF ONCOLOGY
- Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials
- (2013) J. W. Valle et al. ANNALS OF ONCOLOGY
- Enhancer of Zeste Homolog 2 (EZH2) Promotes Progression of Cholangiocarcinoma Cells by Regulating Cell Cycle and Apoptosis
- (2013) Shigeki Nakagawa et al. ANNALS OF SURGICAL ONCOLOGY
- Histone Deacetylases and their Inhibitors as Potential Therapeutic Drugs for cholangiocarcinoma - Cell Line findings
- (2013) Ruethairat Sriraksa et al. Asian Pacific Journal of Cancer Prevention
- Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion – An extension of the ALPPS approach
- (2013) Ch. Tschuor et al. EJSO
- Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
- (2013) Sumera Rizvi et al. GASTROENTEROLOGY
- Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes
- (2013) Daniela Sia et al. GASTROENTEROLOGY
- Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis
- (2013) Guru Trikudanathan et al. GASTROINTESTINAL ENDOSCOPY
- Mesothelin Expression Is a Prognostic Factor in Cholangiocellular Carcinoma
- (2013) Ryohei Nomura et al. INTERNATIONAL SURGERY
- Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis
- (2013) Massimo Iavarone et al. JOURNAL OF HEPATOLOGY
- BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinoma
- (2013) Benjamin Goeppert et al. MODERN PATHOLOGY
- Exome sequencing identifies distinct mutational patterns in liver fluke–related and non-infection-related bile duct cancers
- (2013) Waraporn Chan-on et al. NATURE GENETICS
- Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
- (2013) Yuchen Jiao et al. NATURE GENETICS
- Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells
- (2013) SHIGEKI NAKAGAWA et al. ONCOLOGY REPORTS
- Mouse model of intrahepatic cholangiocarcinoma validates FIG-ROS as a potent fusion oncogene and therapeutic target
- (2013) A. Saborowski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
- (2013) D. Rohle et al. SCIENCE
- Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation
- (2013) F. Wang et al. SCIENCE
- Identification of Targetable FGFR Gene Fusions in Diverse Cancers
- (2013) Yi-Mi Wu et al. Cancer Discovery
- Right Portal Vein Ligation Combined With In Situ Splitting Induces Rapid Left Lateral Liver Lobe Hypertrophy Enabling 2-Staged Extended Right Hepatic Resection in Small-for-Size Settings
- (2012) Andreas A. Schnitzbauer et al. ANNALS OF SURGERY
- Radiological staging in patients with hilar cholangiocarcinoma: a systematic review and meta-analysis
- (2012) A T Ruys et al. BRITISH JOURNAL OF RADIOLOGY
- Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
- (2012) J. C. Mertens et al. CANCER RESEARCH
- Yttrium-90 Radioembolization for Unresectable Standard-chemorefractory Intrahepatic Cholangiocarcinoma: Survival, Efficacy, and Safety Study
- (2012) Shoaib Rafi et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers
- (2012) Sarwa Darwish Murad et al. GASTROENTEROLOGY
- Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders
- (2012) Jochen Metzger et al. GUT
- Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma
- (2012) Benjamin R. Kipp et al. HUMAN PATHOLOGY
- Intracellular localization of mesothelin predicts patient prognosis of extrahepatic bile duct cancer
- (2012) FUTOSHI KAWAMATA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis
- (2012) Anne M. Horgan et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Gene Expression Profiling to Predict the Tissue of Origin and Direct Site-Specific Therapy in Patients With Carcinoma of Unknown Primary Site: A Prospective Trial of the Sarah Cannon Research Institute
- (2012) John D. Hainsworth et al. JOURNAL OF CLINICAL ONCOLOGY
- Typical and Atypical Imaging Findings of Intrahepatic Cholangiocarcinoma Using Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid–Enhanced Magnetic Resonance Imaging
- (2012) So Hee Kim et al. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY
- Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma
- (2012) William C. Palmer et al. JOURNAL OF HEPATOLOGY
- Transarterial Hepatic Yttrium-90 Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: Factors Associated with Prolonged Survival
- (2011) Ralf-T. Hoffmann et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma
- (2011) S.-Y. Park et al. CLINICAL RADIOLOGY
- The efficacy of portal vein embolization prior to right extended hemihepatectomy for hilar cholangiocellular carcinoma: A retrospective cohort study
- (2011) Y.K. Hong et al. EJSO
- Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success
- (2011) Thomas J. Vogl et al. INTERNATIONAL JOURNAL OF CANCER
- Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers
- (2011) Tanios Bekaii-Saab et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Value of Cirrhosis for Intrahepatic Cholangiocarcinoma After Surgical Treatment
- (2011) Ya-yong Li et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Rising trends in cholangiocarcinoma: Is the ICD classification system misleading us?
- (2011) Shahid A. Khan et al. JOURNAL OF HEPATOLOGY
- Portal Vein Resection in Management of Hilar Cholangiocarcinoma
- (2011) Alan W. Hemming et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping
- (2011) D. R. Borger et al. ONCOLOGIST
- Survey of Tyrosine Kinase Signaling Reveals ROS Kinase Fusions in Human Cholangiocarcinoma
- (2011) Ting-Lei Gu et al. PLoS One
- Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination
- (2011) Julie K. Heimbach et al. HPB
- Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
- (2010) T Okusaka et al. BRITISH JOURNAL OF CANCER
- Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol
- (2010) Matthew V. Kiefer et al. CANCER
- Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma
- (2010) Horlad Hasita et al. CANCER SCIENCE
- Role of EUS for preoperative evaluation of cholangiocarcinoma: a large single-center experience
- (2010) Mehdi Mohamadnejad et al. GASTROINTESTINAL ENDOSCOPY
- Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis
- (2010) Tim O. Lankisch et al. HEPATOLOGY
- Radiation Dose–Volume Effects in the Stomach and Small Bowel
- (2010) Brian D. Kavanagh et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiation-Associated Liver Injury
- (2010) Charlie C. Pan et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiotherapy in the Treatment of Patients With Unresectable Extrahepatic Cholangiocarcinoma
- (2010) A. Paiman Ghafoori et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Trends in the incidence and management of biliary tract cancer: A French population-based study
- (2010) Côme Lepage et al. JOURNAL OF HEPATOLOGY
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liver transplantation for cholangiocarcinoma
- (2010) Charles B. Rosen et al. TRANSPLANT INTERNATIONAL
- Intrahepatic Cholangiocarcinoma
- (2009) Itaru Endo et al. ANNALS OF SURGERY
- The Prognosis and Survival Outcome of Intrahepatic Cholangiocarcinoma Following Surgical Resection: Association of Lymph Node Metastasis and Lymph Node Dissection with Survival
- (2009) Sae-Byeol Choi et al. ANNALS OF SURGICAL ONCOLOGY
- Descriptive epidemiology of cholangiocarcinoma in Italy
- (2009) Domenico Alvaro et al. DIGESTIVE AND LIVER DISEASE
- Cholangiocarcinoma in cirrhosis: Absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma
- (2009) Jordi Rimola et al. HEPATOLOGY
- Radiotherapy Is Associated With Improved Survival in Adjuvant and Palliative Treatment of Extrahepatic Cholangiocarcinomas
- (2009) Eric T. Shinohara et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Cholangiocarcinoma: lessons from Thailand
- (2008) Banchob Sripa et al. CURRENT OPINION IN GASTROENTEROLOGY
- MR imaging and MR cholangiopancreatography in the preoperative evaluation of hilar cholangiocarcinoma: correlation with surgical and pathologic findings
- (2008) Gabriele Masselli et al. EUROPEAN RADIOLOGY
- Misleading figures on trends in mortality from hepatocellular carcinoma in europe
- (2008) Ann-Sofi Duberg et al. HEPATOLOGY
- Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis
- (2008) Phunchai Charatcharoenwitthaya et al. HEPATOLOGY
- Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
- (2008) Regina V. Tse et al. JOURNAL OF CLINICAL ONCOLOGY
- Staging cholangiocarcinoma by imaging studies
- (2008) V. Vilgrain HPB
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search